Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ).
WuXi AppTec Co., Ltd. has issued a positive profit alert, anticipating a significant increase in revenue and net profit for the first half of 2025 compared to the same period in 2024. The company expects a revenue of approximately RMB20,799.28 million, marking a 20.64% year-over-year increase, and a net profit attributable to owners of approximately RMB8,560.88 million, a 101.92% increase, driven by operational efficiencies and a gain from the sale of shares in an associate.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$71.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. operates in the pharmaceutical and biotechnology industry, focusing on its unique, integrated, and end-to-end Contract Research, Development, and Manufacturing Organization (CRDMO) business model. The company enhances its capabilities and capacity to meet customer demand for enabling services, optimizing production processes, and improving operating efficiency to deliver groundbreaking therapies globally.
Average Trading Volume: 6,603,169
Technical Sentiment Signal: Buy
Current Market Cap: HK$217.3B
Find detailed analytics on 2359 stock on TipRanks’ Stock Analysis page.